Celsius (NASDAQ:CELH) Now Covered by JPMorgan Chase & Co.

JPMorgan Chase & Co. initiated coverage on shares of Celsius (NASDAQ:CELH) in a research report sent to investors on Thursday morning, Marketbeat Ratings reports. The brokerage issued an overweight rating and a $37.00 target price on the stock.

CELH has been the subject of several other reports. Piper Sandler lowered their price target on Celsius from $50.00 to $47.00 and set an “overweight” rating for the company in a report on Tuesday, September 24th. Truist Financial increased their target price on Celsius from $30.00 to $35.00 and gave the company a “hold” rating in a research note on Wednesday, October 16th. Morgan Stanley reiterated an “equal weight” rating and set a $50.00 target price on shares of Celsius in a report on Tuesday, August 20th. UBS Group decreased their price target on Celsius from $50.00 to $45.00 and set a “buy” rating for the company in a report on Thursday, November 7th. Finally, Needham & Company LLC began coverage on shares of Celsius in a research note on Friday, December 6th. They set a “buy” rating and a $38.00 price objective on the stock. One analyst has rated the stock with a sell rating, four have assigned a hold rating and thirteen have assigned a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $51.28.

Celsius Stock Up 0.4 %

Shares of CELH stock opened at $32.12 on Thursday. Celsius has a fifty-two week low of $25.23 and a fifty-two week high of $99.62. The firm’s 50 day moving average price is $30.02 and its two-hundred day moving average price is $42.17. The stock has a market cap of $7.55 billion, a price-to-earnings ratio of 44.43, a price-to-earnings-growth ratio of 3.44 and a beta of 1.76.

Hedge Funds Weigh In On Celsius

Several institutional investors have recently modified their holdings of CELH. Livforsakringsbolaget Skandia Omsesidigt bought a new stake in Celsius in the 3rd quarter valued at about $34,000. Signaturefd LLC increased its stake in shares of Celsius by 48.3% in the third quarter. Signaturefd LLC now owns 1,160 shares of the company’s stock valued at $36,000 after purchasing an additional 378 shares during the period. Benjamin F. Edwards & Company Inc. raised its holdings in shares of Celsius by 353.1% during the second quarter. Benjamin F. Edwards & Company Inc. now owns 648 shares of the company’s stock valued at $37,000 after buying an additional 505 shares during the last quarter. Newbridge Financial Services Group Inc. boosted its position in shares of Celsius by 3,150.0% during the second quarter. Newbridge Financial Services Group Inc. now owns 650 shares of the company’s stock worth $37,000 after buying an additional 630 shares during the period. Finally, Activest Wealth Management bought a new position in Celsius in the 3rd quarter worth approximately $39,000. Institutional investors own 60.95% of the company’s stock.

Celsius Company Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.